Pharma Journalist -

Fresenius Kabi announced the immediate availability in the United States of Leucovorin Calcium Injection, USP, a medication indicated to counteract the toxicity and diminish the effects…
Read More...

Triphase Accelerator, together with its majority shareholder FACIT, announced a new strategic collaboration with Celgene for a first-in-class preclinical therapeutic targeting the WDR5…
Read More...

The WIRB-Copernicus Group's (WCG) Clinical Services Division has partnered with Prudentia Group to deliver a comprehensive solution to enhance the quality, safety and regulatory…
Read More...

SMi presents its 13th annual Parallel Trade conference happening in just one week. The highly anticipated event provides the perfect platform for industry experts to come together and…
Read More...

Horizon Discovery Group plc announces that it has entered into an exclusive strategic partnership with Rutgers, The State University of New Jersey (US), to develop and commercialise a…
Read More...

SMi Group’s next 11th annual conference is thrilled to welcome Heiko Goette, Biostatistician from Merck speaking about simulated development programs that are shaping state of the art…
Read More...

BioDuro and Advent International announced a partnership to support BioDuro's growth as a premier provider of integrated drug discovery, development and manufacturing services. Under…
Read More...

Orgenesis Inc. announced that its subsidiary, Masthercell Global Inc., is expanding into the United States and has executed a lease agreement to build a new 30,000 sq. ft manufacturing…
Read More...

Olon S.p.A. announced the acquisition of Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation, as part of a continuing expansion of its…
Read More...

Concert Pharmaceuticals announced that it has initiated the second Phase 1 clinical trial with CTP-692, a novel deuterium-modified form of D-serine being developed as an adjunctive…
Read More...